🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Masachuset › Worcester

Kliničke studije za Немалоклетни карцином плућа u gradu Worcester, MA

14 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Worcester i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Тражи се учесникФаза 3
  • Reliant Medical Group Inc, Worcester
Узраст од 18 до 100 · Оба пола · Ажурирано 13. 11. 2026. · NCT05920356

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Тражи се учесникФаза 3
  • UMass Memorial Medical Center - University Campus, Worcester
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Тражи се учесникФаза 3
  • UMass Memorial Medical Center - University Campus, Worcester
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Тражи се учесникФаза 3
  • University of Massachusetts Memorial Medical Center, Worcester
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06472245

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 3
  • University of Massachusetts Worcester, Worcester
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07144280

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • University of Massachusetts Memorial Medical Center, Worcester
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06793215

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Reliant Medical Group, Worcester
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06890598

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Тражи се учесникФаза 2/3
  • Dana-Farber Brigham and Womens Cancer Center at Milford Regional, Milford · 17 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT04613596

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • UMass Memorial Medical Center - University Campus, Worcester
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • UMass Memorial Medical Center - University Campus, Worcester
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2/3
  • UMass Memorial Medical Center - University Campus, Worcester
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Тражи се учесникФаза 3
  • Clinical Study Site, Worcester
  • Clinical Study Site, Milford · 17 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06767514

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • UMass Memorial Medical Center - University Campus, Worcester
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Worcester
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Studije za Немалоклетни карцином плућа u drugim gradovima

Ostale studije u gradu Worcester

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.